AbbVie boosts cancer drug pipeline with $21 bln Pharmacyclics deal

AbbVie Inc is to buy Pharmacyclics Inc for about $ 21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. …
world drug news – Yahoo News Search Results

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us